Survival among Patients with HIV Infection and Smear-Negative Pulmonary Tuberculosis - United States, 1993-2006

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Cavanaugh, J Sean ^a   Shah, N Sarita ^a,b   Cain, Kevin P ^a   Winston, Carla A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HAZARD RATIO; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK ASSESSMENT; SPUTUM SMEAR; SURVIVAL RATE; THERAPY DELAY; TREATMENT DURATION; TREND STUDY; UNITED STATES;

FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; SEX FACTORS; SPUTUM; SURVIVAL ANALYSIS; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 84867871715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047855     Document Type: Article

References (43)

1. Colebunders R, Bastian I, (2000) A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 4: 97-107.
2. Smear-negative pulmonary tuberculosis. Tubercle 61: 113-115.
3. Narain R, Nair SS, Naganna K, Chandrasekhar P, Rao GR, et al. (1968) Problems in defining a "case" of pulmonary tuberculosis in prevalence surveys. Bull World Health Organ 39: 701-729.
4. National Tuberculosis Institute (1974) Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Health Organ 51: 473-488.
5. National Tuberculosis Institute (1981) A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis. Tubercle 62: 155-167.
6. Harries AD, Dye C, (2006) Tuberculosis. Ann Trop Med Parasitol 100: 415-431.
7. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P (1997) Tuberculosis and HIV: current status in Africa. AIDS 11 Suppl B: S115-123.
8. Harries AD, Hargreaves NJ, Kemp J, Jindani A, Enarson DA, et al. (2001) Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 357: 1519-1523.
9. Harries AD, Nyirenda TE, Banerjee A, Boeree MJ, Salaniponi FM, (1999) Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Trans R Soc Trop Med Hyg 93: 443-446.
10. Kang'ombe CT, Harries AD, Ito K, Clark T, Nyirenda TE, et al. (2004) Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int J Tuberc Lung Dis 8: 829-836.
11. Hargreaves NJ, Kadzakumanja O, Phiri S, Lee CH, Tang X, et al. (2001) Pneumocystis carinii pneumonia in patients being registered for smear-negative pulmonary tuberculosis in Malawi. Trans R Soc Trop Med Hyg 95: 402-408.
12. Hargreaves NJ, Kadzakumanja O, Phiri S, Nyangulu DS, Salaniponi FM, et al. (2001) What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence? Int J Tuberc Lung Dis 5: 113-122.
13. Salaniponi FM, Gausi F, Kwanjana JH, Harries AD, (2000) Time between sputum examination and treatment in patients with smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 4: 581-583.
14. Storla DG, Yimer S, Bjune GA, (2008) A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8: 15.
15. Lawn SD, Shattock RJ, Griffin GE, (1997) Delays in the diagnosis of tuberculosis: a great new cost. Int J Tuberc Lung Dis 1: 485-486.
16. LoBue PA, Enarson DA, Thoen TC, (2010) Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int J Tuberc Lung Dis 14: 1226-1232.
17. Centers for Disease Control and Prevention (2009) Reported Tuberculosis in the United States, 2008. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention.
18. Centers for Disease Control and Prevention (2009) Report of Verified Case of Tuberculosis (RVCT), Instruction Manual. Available: http://www.cdc.gov/tb/programs/rvct/InstructionManual.pdf. Accessed: August 10, 2012.
19. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July (1999) This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 161: 1376-1395.
20. Curtis AB, McCray E, McKenna M, Onorato IM, (2001) Completeness and timeliness of tuberculosis case reporting. A multistate study. Am J Prev Med 20: 108-112.
21. Hargreaves NJ, Kadzakumanja O, Whitty CJ, Salaniponi FM, Harries AD, et al. (2001) 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis 5: 847-854.
22. Kang'ombe C, Harries AD, Banda H, Nyangulu DS, Whitty CJ, et al. (2000) High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up. Trans R Soc Trop Med Hyg 94: 305-309.
23. Connolly C, Davies GR, Wilkinson D, (1998) Impact of the human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991-1995. Int J Tuberc Lung Dis 2: 919-925.
24. Johnson JL, Vjecha MJ, Okwera A, Hatanga E, Byekwaso F, et al. (1998) Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration. Int J Tuberc Lung Dis 2: 397-404.
25. Perkins MD, Cunningham J, (2007) Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 196Suppl 1: S15-27.
26. Siddiqi K, Lambert ML, Walley J, (2003) Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 3: 288-296.
27. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. MMWR Recomm Rep 55: 1-44.
28. Lawn SD, Evans AJ, Sedgwick PM, Acheampong JW, (1999) Pulmonary tuberculosis: radiological features in west Africans coinfected with HIV. Br J Radiol 72: 339-344.
29. Post FA, Wood R, Pillay GP, (1995) Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. Tuber Lung Dis 76: 518-521.
30. Matsuoka S, Uchiyama K, Shima H, Suzuki K, Shimura A, et al. (2004) Relationship between CT findings of pulmonary tuberculosis and the number of acid-fast bacilli on sputum smears. Clin Imaging 28: 119-123.
31. Mugusi F, Villamor E, Urassa W, Saathoff E, Bosch RJ, et al. (2006) HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int J Tuberc Lung Dis 10: 663-669.
32. Singhal S, Mahajan SN, Diwan SK, Gaidhane A, Quazi ZS, (2011) Correlation of sputum smear status with CD4 count in cases of pulmonary tuberculosis and HIV co-infected patients-a hospital based study in a rural area of Central India. Indian J Tuberc 58: 108-112.
33. Karstaedt AS, Jones N, Khoosal M, Crewe-Brown HH, (1998) The bacteriology of pulmonary tuberculosis in a population with high human immunodeficiency virus seroprevalence. Int J Tuberc Lung Dis 2: 312-316.
34. Samb B, Sow PS, Kony S, Maynart-Badiane M, Diouf G, et al. (1999) Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc Lung Dis 3: 330-336.
35. Tamhane A, Chheng P, Dobbs T, Mak S, Sar B, et al. (2009) Predictors of smear-negative pulmonary tuberculosis in HIV-infected patients, Battambang, Cambodia. Int J Tuberc Lung Dis 13: 347-354.
36. Lawn SD, Kerkhoff AD, Vogt M, Wood R, (2012) Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 12: 201-209.
37. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, et al. (2010) An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 362: 707-716.
38. World Health Organization (2006) Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings. Geneva, Switzerland.
39. Harries AD, Nyirenda TE, Godfrey-Faussett P, Salaniponi FM, (2003) Defining and assessing the maximum number of visits patients should make to a health facility to obtain a diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis 7: 953-958.
40. Mukadi YD, Maher D, Harries A, (2001) Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 15: 143-152.
41. Getahun H, Harrington M, O'Brien R, Nunn P, (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369: 2042-2049.
42. Okwera A, Whalen C, Byekwaso F, Vjecha M, Johnson J, et al. (1994) Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration. Lancet 344: 1323-1328.
43. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, et al. (2006) Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 6: 570-581.